Project Description

In an age where 80% of the economy is service-based, pharma is also reinventing its model. And as new technologies are enabling untapped insights into the human body, wearables may serve as the foundation of a “beyond the pill” approach to delivering value.This session will explore the future of personalized medicine, and how an unconventional partnership between Pharma and Wearable Tech is disrupting healthcare.


John Nosta, President, NostaLab


Nirav ‘Rav’ Sheth, Director of Market Development, Medical, MC10 Inc.
Michael Cantor, MD, JD, Chief Medical Officer, New England Quality Care Alliance
Dr. James Zackheim, PhD, Vice President & Neupro Patient Solutions Leader, UCB, Inc.